OUR VISION
Developed by Nature, Validated by Science.
Our mission is to develop a range of dermatological treatments utilising specific properties from plants with the goal of creating plant-based pharmaceuticals (PMPs) for commercialisation. These treatments will target common skin conditions, including, Acne, Eczema, Psoriasis and Alopecia.
Discover PipelineOUR STORY
Focused Plant Science for Dermatology
Derma Biosciences is focused on plant-derived therapeutics with a core dermatological focus. The scientific team have 80+ years of research and clinical experience led by Professor Tony Chu, ex-head of Dermatology at Imperial College, London, who is a world authority on Acne and other skin conditions.
Our aim is to deliver affordable, affective and sustainable treatments to the world’s fourth most common disease, effecting a third of the global population. Dermatological diseases can also cause serious secondary illnesses such as mental health conditions, furthermore, there is believed to be a direct link between eczema, asthma and allergies developed during infancy (Atopic March).
Years of research
by 2025 expected skincare market size
CAGR
